Innoviva, Inc. (INVA) Revenue History
Innoviva, Inc. (INVA) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $133.57M |
| 2017-12-31 | $217.22M |
| 2018-12-31 | $261.00M |
| 2019-12-31 | $261.02M |
| 2020-12-31 | $336.79M |
| 2021-12-31 | $391.87M |
| 2022-12-31 | $331.34M |
| 2023-12-31 | $310.46M |
| 2024-12-31 | $358.71M |
| 2025-12-31 | $411.33M |
How INVA compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| VCYT | Veracyte Inc. | $517.14M |
| ADMA | ADMA Biologics Inc | $510.17M |
| KRYS | Krystal Biotech Inc. | $389.13M |
| MNKD | MannKind Corporation | $348.97M |
| FLGT | Fulgent Genetics Inc. | $322.67M |
These are five companies in the same sector as INVA with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Innoviva, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("INVA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | INVA | $21.24 | +0.33% | 0.69M |
| 3 | ||||
| 4 | ||||
| 5 |